Ilumya (tildrakizumab-asmn)
Billing
Code: J3245
Description: Inj., tildrakizumab, 1 mg
Unit: 1 mg
Payment: $142.222
Pay quarter: Q4 2023
Dosage and Frequency
Calculate drug reimbursement
Total Reimbursement:
$14,222.20(ASP: $13,417.17, Margin: $805.03)
Code:
J3245# Units to bill:
100Prior Authorization
Prior auth criteria for Ilumya may include but is not limited to:
Insurance prior auth guidelines:
Billable NDCs
47335-0177-95
Ilumya (SUN PHARMACEUTICAL GLOBAL FZE.)
100 MG
Resources